secwatch / observer
8-K filed May 5, 2026, 7:59 PM ET ticker IPGP CIK 0001111928
other material confidence high sentiment neutral materiality 0.65

IPG Photonics Q1 revenue up 17% to $265.5M; settles global patent litigation with Trumpf

IPG PHOTONICS CORP

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001111928-26-000094
form_type
8-K
ticker
IPGP
cik
0001111928
company_name
IPG PHOTONICS CORP
filed_at
2026-05-05T23:59:59+00:00
discovered_at
2026-05-14T18:02:31.969527+00:00
generated_at
2026-05-14T23:13:12.858893+00:00
sec_items
["2.02", "8.01", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.65
calibrated_materiality_score
0.65
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001111928-26-000094
json_url
https://secwatch.observer/filing/0001111928-26-000094.json
markdown_url
https://secwatch.observer/filing/0001111928-26-000094.md
text_url
https://secwatch.observer/filing/0001111928-26-000094.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/0001111928-26-000094-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1111928/000111192826000094/ipgp-20260505.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

c7b1359f53932755199b5f8dee9df02bafd7a7b2

IPG PHOTONICS CORP reported first quarter ended March 31, 2026 results: revenue $265.5, net income $1.6, EPS $0.04. Guidance initiated.

Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %

SEC 8-K Item 2.02 confidence 0.9 SEC evidence

Comparable filings

ARTV

Artiva reports 71% ACR50 in refractory RA at 6 months, FDA alignment for Phase 3 trial; Q1 net loss $23.5M

Artiva Biotherapeutics, Inc. May 8, 2026, 7:59 PM ET other_material Items 2.02, 7.01, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 same event type: other_material

This filing

Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %

Comparable filing

Artiva Biotherapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended March 31, 2026.

Filing page SEC filing

YEXT

Yext Q1 FY27: Adj EBITDA margin 25%, ARR $440.8M; boosts buyback by $100M

Yext, Inc. June 2, 2026, 4:05 PM ET earnings Items 2.02, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 similar materiality

This filing

Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %

Comparable filing

Exchange Act, except as expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Yext Announces First Quarter Fiscal 2027 Results – Revenue of $107.9 million – Net Income Per Share, basic, of $0.02 or non-GAAP Net Income Per Share of $0.15 – Adjusted EBITDA of $26.9 million, resulting in an Adjusted EBITDA margin of 25% – ARR of

Filing page SEC filing

SNDA

Sonida Senior Living reports Q1 net loss of $41.2M; revenue up 37% on CHP acquisition

SONIDA SENIOR LIVING, INC. May 11, 2026, 7:59 PM ET earnings Items 2.02, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 similar materiality

This filing

Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %

Comparable filing

Sonida Senior Living Announces First Quarter 2026 Results DALLAS, Texas – May 11, 2026 – Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the first quarter ended March 31, 2026.

Filing page SEC filing

LXEO

Lexeo Therapeutics Q1 net loss $20.2M; cash $227.6M; LX2006 pivotal trial protocol submitted to FDA

Lexeo Therapeutics, Inc. May 11, 2026, 7:59 PM ET earnings Items 2.02, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 similar materiality

This filing

Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %

Comparable filing

Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights

Filing page SEC filing

CRON

Cronos Q1 net revenue up 40% to $45.2M; authorizes $50M share buyback; CanAdelaar close extended to Sep 9

Cronos Group Inc. May 11, 2026, 7:59 PM ET earnings Items 1.01, 2.02, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 similar materiality

This filing

Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %

Comparable filing

reference in such a filing or document. --- EX-99.1 (EX-99.1) --- Cronos Group Reports 2026 First Quarter Results Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada 1 Ninth consecutive quarter of record net revenue in Israel, where PEACE

Filing page SEC filing

CERT

Certara Q1 revenue $106.9M (+1%), net loss $8.8M; divests Regulatory Writing for $85M cash

Certara, Inc. May 11, 2026, 7:59 PM ET earnings Items 2.02, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 similar materiality

This filing

Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %

Comparable filing

First Quarter 2026 Results Total revenue for the first quarter of 2026 was $106.9 million, representing year-over-year growth of 1% on a reported basis. Software revenue for the first quarter of 2026 was $49.7 million, representing year-over-year growth of 7% on a reported basis. Services revenue for the first quarter of 2026 was $57.2 million, representing a year-over-year decrease of 4% on a reported basis . Total Bookings for the first quarter of 2026 were $115.3 million, representing a year-over-year decrease of 2%. Software Bookings for the first quarter of 2026 were $48.7 million, representing a year-over-year increase of 20%. The increase in software bookings was attributable to strong customer demand across our platform. Services Bookings for the first quarter of 2026 were $66.6 million, representing a year-over-year decrease of 14%. The decrease in services bookings was primarily driven by the timing of contract recognition and execution. Total cost of revenues for the first q

Filing page SEC filing

RPC

Ridgepost Capital reports record AUM of $31B in Q1 2026, up 18% YoY

Ridgepost Capital, Inc. May 8, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 similar materiality

This filing

Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %

Comparable filing

Ridgepost Capital, Inc (NYSE: RPC), a leading private markets solutions provider, today announced financial results for the first quarter ended March 31, 2026.

Filing page SEC filing

ASIX

AdvanSix Q1 net loss $15.5M; sales up 7% to $404M; declares $0.16 dividend; appoints new CFO

AdvanSix Inc. May 8, 2026, 7:59 PM ET earnings Items 2.02, 8.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 8.01, 9.01 similar materiality

This filing

Three Months Ended March 31, (In millions, except per share data and percentages) 2026 2025 Change Revenue $ 265.5 $ 227.8 17 % Gross margin 37.5 % 39.4 % Operating income (loss) $ (7.7) $ 1.8 NM Operating margin (2.9) % 0.8 % Net income $ 1.6 $ 3.8 (58) % Earnings per diluted share $ 0.04 $ 0.09 (56) %

Comparable filing

the second quarter." Summary first quarter 2026 financial results for the Company are included below: 1 ( $ in Thousands, Except Earnings Per Share) 1Q 2026 1Q 2025 (1) Sales $404,183 $377,791 Net Income (loss) (15,546) 23,344 Diluted Earnings Per Share (0.58) 0.86 Adjusted Diluted Earnings Per Share (2) (0.50) 0.93 Adjusted EBITDA (2) 4,756 51,626 Adjusted

Filing page SEC filing

Source: SEC EDGAR
accession 0001111928-26-000094

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.